Yoon Jeong, Yoon Hye-Jin, Juhn Kyoung-Mi, Ko Jin-Kyung, Yoon San-Hyun, Ko Yong, Lim Jin-Ho
Maria Research Center, Seoul, Korea.
Clin Exp Reprod Med. 2011 Dec;38(4):186-92. doi: 10.5653/cerm.2011.38.4.186. Epub 2011 Dec 31.
Since IVF program was first established, various types of media and culture systems have been developed either in-house or commercially. The aim of this study was to compare the efficacy of in-house Maria Research Center (MRC) media to that of commercially available Sydney IVF media in human day 3 embryo transfer cycles.
Three hundred sixty nine couples were included in this prospective, randomized, and comparative study. All couples undergoing IVF treatment at the Maria Fertility Hospital were randomly assigned to either Sydney IVF (n=178) or MRC (n=191) media.
No difference was observed between the MRC media and Sydney IVF media groups with respect to fertilization rate (74.4% vs. 75.5%). The clinical pregnancy and implantation rates of MRC media (47.1% and 20.0%, respectively) were also similar to those of Sydney IVF media (44.4% and 19.4%, respectively). However, the proportion of embryos with good quality on day 3 was significantly higher in the MRC media group than the Sydney IVF media group (50.2% vs. 43.2%) (p<0.05).
MRC media were as effective as Sydney IVF media for sustaining embryo development and pregnancy rates. The present study implies that MRC media can be a suitable alternative to commercially available media for human IVF-ET program.
自体外受精项目首次建立以来,已研发出各种类型的培养基和培养系统,既有自行研发的,也有商业产品。本研究的目的是比较自行研发的玛丽亚研究中心(MRC)培养基与市售悉尼体外受精培养基在人类第3天胚胎移植周期中的效果。
369对夫妇纳入了这项前瞻性、随机对照比较研究。所有在玛丽亚生育医院接受体外受精治疗的夫妇被随机分配至悉尼体外受精组(n = 178)或MRC组(n = 191),分别使用相应的培养基。
MRC培养基组与悉尼体外受精培养基组在受精率方面无差异(分别为74.4%和75.5%)。MRC培养基组的临床妊娠率和着床率(分别为47.1%和20.0%)也与悉尼体外受精培养基组相似(分别为44.4%和19.4%)。然而,第3天优质胚胎的比例在MRC培养基组显著高于悉尼体外受精培养基组(分别为50.2%和43.2%)(p<0.05)。
MRC培养基在维持胚胎发育和妊娠率方面与悉尼体外受精培养基同样有效。本研究表明,对于人类体外受精-胚胎移植项目,MRC培养基可以作为市售培养基的合适替代品。